Today, the firm appears to be overvalued. Health In Tech retains a regular Real Value of USD1.16 per share. The prevalent price of the firm is USD1.21. Our model calculates the value of Health In Tech from evaluating the firm fundamentals such as return on equity of 0.12, and Return On Asset of 0.0533 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Health In's valuation include:
Price Book
4.0462
Enterprise Value
61.6 M
Enterprise Value Ebitda
23.3804
Price Sales
2.2413
Trailing PE
60.5
Overvalued
Today
1.21
Please note that Health In's price fluctuation is abnormally volatile at this time. Calculation of the real value of Health In Tech is based on 3 months time horizon. Increasing Health In's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Health In's intrinsic value may or may not be the same as its current market price of 1.21, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical
Market 1.21
Real 1.16
Hype 1.21
Naive 1.27
The intrinsic value of Health In's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Health In's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Health In Tech helps investors to forecast how Health stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Health In more accurately as focusing exclusively on Health In's fundamentals will not take into account other important factors:
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Health In's intrinsic value based on its ongoing forecasts of Health In's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Health In's closest peers.
Health In Cash
9.48 Million
Health In Total Value Analysis
Health In Tech is currently forecasted to have company total value of 61.56 M with market capitalization of 68.86 M, debt of 206.69 K, and cash on hands of 7.05 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Health In fundamentals before making security assessment based on enterprise value of the company
About 75.0% of the company shares are held by company insiders. The book value of Health In was currently reported as 0.3. The company last dividend was issued on the September 28, 2011. Based on the analysis of Health In's profitability, liquidity, and operating efficiency, Health In Tech is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Health In has an asset utilization ratio of 123.61 percent. This implies that the Company is making USD1.24 for each dollar of assets. An increasing asset utilization means that Health In Tech is more efficient with each dollar of assets it utilizes for everyday operations.
Covid
Interest Hikes
Health In Profitability Analysis
Considering Health In's profitability and operating efficiency indicators, Health In Tech is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in March. Profitability indicators assess Health In's ability to earn profits and add value for shareholders.
Net Income
First Reported
2010-12-31
Previous Quarter
771 K
Current Value
1.2 M
Quarterly Volatility
634.6 K
Credit Downgrade
Yuan Drop
Covid
Interest Hikes
At this time, Health In's Pretax Profit Margin is comparatively stable compared to the past year. Operating Profit Margin is likely to gain to 0.07 in 2026, whereas Gross Profit is likely to drop slightly above 13.8 M in 2026.
For Health In profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Health In Tech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Health In utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Health In's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Health In over time as well as its relative position and ranking within its peers.
Health In Earnings per Share Projection vs Actual
By analyzing Health In's earnings estimates, investors can diagnose different trends across Health In's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Health In Tech is based on EPS before non-recurring items and includes expenses related to employee stock options.
Covid
Interest Hikes
Health In is projected to generate -0.01 in earnings per share on the 31st of March 2026. Health In earnings estimates show analyst consensus about projected Health In EPS (Earning Per Share). It derives the highest and the lowest estimates based on Health In's historical volatility. Many public companies, such as Health In, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.
Health In Ownership Allocation
Health In Tech has a total of 45.21 Million outstanding shares. Health In retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.57 (percent) of Health In outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Health In Profitability Analysis
The company reported the last year's revenue of 19.49 M. Total Income to common stockholders was 670.48 K with profit before taxes, overhead, and interest of 20.61 M.
About Health In Valuation
The stock valuation mechanism determines Health In's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Health In Tech based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Health In. We calculate exposure to Health In's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Health In's related companies.
Investing in growth stocks can be very risky. If the company such as Health In does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding
53.7 M
Quarterly Earnings Growth Y O Y
0.103
Health In Current Valuation Indicators
Health In's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Health In's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Health In, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Health In's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Health In's worth.
Additional Tools for Health Stock Analysis
When running Health In's price analysis, check to measure Health In's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health In is operating at the current time. Most of Health In's value examination focuses on studying past and present price action to predict the probability of Health In's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health In's price. Additionally, you may evaluate how the addition of Health In to your portfolios can decrease your overall portfolio volatility.